EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

β-catenin mediates growth defects induced by centrosome loss in a subset of APC mutant colorectal cancer independently of p53

Mohamed Bourmoum, Nikolina Radulovich, Amit Sharma iD, Johnny M Tkach, Ming-Sound Tsao iD, Laurence Pelletier iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0295030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Mohamed Bourmoum und 5 weiteren Autor:innen. Beteiligte Einrichtung: Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada. Hauptthemen laut MEDLINE: beta Catenin, Colorectal Neoplasms, Tumor Suppressor Protein p53, Adenomatous Polyposis Coli Protein. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Krembil Foundation, CCSRI, Canadian Institutes for Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer is the third most common cancer and the second leading cause of cancer-related deaths worldwide. The centrosome is the main microtubule-organizing center in animal cells and centrosome amplification is a hallmark of cancer cells. To investigate the importance of centrosomes in colorectal cancer, we induced centrosome loss in normal and cancer human-derived colorectal organoids using centrinone B, a Polo-like kinase 4 (Plk4) inhibitor. We show that centrosome loss represses human normal colorectal organoid growth in a p53-dependent manner in accordance with previous studies in cell models. However, cancer colorectal organoid lines exhibited different sensitivities to centrosome loss independently of p53. Centrinone-induced cancer organoid growth defect/death positively correlated with a loss of function mutation in the APC gene, suggesting a causal role of the hyperactive WNT pathway. Consistent with this notion, β-catenin inhibition using XAV939 or ICG-001 partially prevented centrinone-induced death and rescued the growth two APC-mutant organoid lines tested. Our study reveals a novel role for canonical WNT signaling in regulating centrosome loss-induced growth defect/death in a subset of APC-mutant colorectal cancer independently of the classical p53 pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta CateninColorectal NeoplasmsTumor Suppressor Protein p53Adenomatous Polyposis Coli ProteinAnimalsHumansCentrosomePyrimidinesSulfonesWnt Signaling Pathway

Substanzen

beta CatenincentrinonePyrimidinesSulfonesTumor Suppressor Protein p53APC protein, humanAdenomatous Polyposis Coli Protein

Autor:innen und Institutionen

  • Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada.
  • University Health Network, Ontario Cancer Institute/Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.

ORCID-Profile: Amit Sharma, Ming-Sound Tsao, Laurence Pelletier

Förderung

  • Krembil Foundation
  • CCSRI
  • Canadian Institutes for Health Research
  • Hold'em for Life Charity Challenge

Zitieren

APA

Bourmoum, M., Radulovich, N., Sharma, A., Tkach, J. M., Tsao, M. S., & Pelletier, L. (2024). β-catenin mediates growth defects induced by centrosome loss in a subset of APC mutant colorectal cancer independently of p53. PLOS ONE. https://doi.org/10.1371/journal.pone.0295030

Vancouver

Bourmoum M, Radulovich N, Sharma A, Tkach JM, Tsao MS, Pelletier L. β-catenin mediates growth defects induced by centrosome loss in a subset of APC mutant colorectal cancer independently of p53. PLOS ONE. 2024. doi:10.1371/journal.pone.0295030

BibTeX
@article{Bourmoum2024,
  author = {Bourmoum, Mohamed and Radulovich, Nikolina and Sharma, Amit and Tkach, Johnny M and Tsao, Ming-Sound and Pelletier, Laurence},
  title = {β-catenin mediates growth defects induced by centrosome loss in a subset of APC mutant colorectal cancer independently of p53},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0295030}
}
Kostenlos starten →